How Merck Is Trying to Keep Disrupters at Bay
Harvard Business Review
JUNE 8, 2015
EB plays the role of a venture capitalist or private-equity board with responsibility to sell, spin-out, or wind-down initiatives that, in practice, are found to be a poor strategic fit. But, because of EB’s diverse set of employees, it’s able to stimulate ideas from other industries and counter “paradigm bigots.”
8 
Let's personalize your content